AI-Driven Strategies: Pharma’s Answer to Patent Expirations

In a recent article in Pharmaceutical Executive, Alan Kalton, Senior Vice President of Commercial Strategy at Aktana, sheds light on the critical challenges facing pharmaceutical companies as they confront impending drug patent expirations and escalating costs in the United States market. With a journalistic perspective, this report delves into the dire financial landscape that pharmaceutical […] Source